Lung cancer and hemostasis – the impact of subclinical thrombotic manifestations upon the prognosis: a prospective hospital study

B. Escarguel, F. Giauffret, V. Thomas, L. Chollet, D. D‘Amore, C. Audigier-Valette, L. Marqueste (Toulon, France)

Source: Annual Congress 2006 - Biology and prognostic factors
Session: Biology and prognostic factors
Session type: Poster Discussion
Number: 2288
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Escarguel, F. Giauffret, V. Thomas, L. Chollet, D. D‘Amore, C. Audigier-Valette, L. Marqueste (Toulon, France). Lung cancer and hemostasis – the impact of subclinical thrombotic manifestations upon the prognosis: a prospective hospital study. Eur Respir J 2006; 28: Suppl. 50, 2288

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study
Source: Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016
Year: 2017



Early symptoms in suspected lung cancer: a prospective cohort study
Source: Eur Respir J 2001; 18: Suppl. 33, 64s
Year: 2001

A retrospective cohort study of patients with pulmonary embolism: the impact of comorbidities on patient's outcome
Source: Eur Respir J 2016; 48: 555-557
Year: 2016


Comparison of risk prediction scores for venous thromboembolism in lung cancer patients: a retrospective cohort study
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019


PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting
Source: International Congress 2014 – ILDs 6
Year: 2014


PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study
Source: Eur Respir J, 50 (1) 1700094; 10.1183/13993003.00094-2017
Year: 2017



Venous thromboembolic disease in patients with small cell lung cancer: incidence and clinicopathological risk factors
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020


Earlier diagnosis and international registries may improve outcomes in pulmonary tumour thrombotic microangiopathy
Source: Eur Respir J 2016; 47: 690-691
Year: 2016


Multi-institutional prospective cohort study of prognostic factors in patients with idiopathic pulmonary fibrosis receiving long-term oxygen therapy.
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019


Clinical characteristics and prognosis in patients with chronic thromboembolic pulmonary hypertension and a psychiatric disorder
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018


Chronic pulmonary aspergillosis in France: prevalence, associated chronic pulmonary diseases and prognosis in a 10-year retrospective study of the French nationwide administrative hospital database.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019

Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease: a retrospective cohort study
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019


Pulmonary embolism (PE): potencial risk factors and discrepancies between clinical and postmortem diagnosis in a referral hospital of lung diseases
Source: Annual Congress 2007 - Venous thromboembolism
Year: 2007


1-year prospective study in severe COPD patients: marker of inflammation, lung function and radiologic evaluation
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


Importance of cardiac biomarkers in the evaluation of acute pulmonary thromboembolism severity, mortality and complicated clinical course
Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases
Year: 2011

Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study
Source: ERJ Open Res, 5 (1) 00014-2019; 10.1183/23120541.00014-2019
Year: 2019



Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976–2013
Source: Eur Respir J , 49 (2) 1601290; DOI: 10.1183/13993003.01290-2016
Year: 2017



Prognostic value of symptoms at lung cancer diagnosis: a two-year observational study
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019

Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry
Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019
Year: 2020